… with neuropsychiatric and QoL impairment in COVID-19. We thus conducted a cross-sectional …
study in COVID-19 survivors posthospitalization to assess the neuropsychiatric and QoL …

… COVID-19 and 61 patients that did not have COVID-19 (control patients) were seen at
approximately 6 months after COVID-19 … the Mini International Neuropsychiatric Interview (MINI) …

… potential COVID-19 associated neuropsychiatric outcomes are … of acute neuropsychiatric
symptoms in the context of COVID-19 … of COVID-19 based on findings from other coronavirus or …

… syndrome coronavirus 2 (SARS-CoV-2), spread across the world and caused what has become
known as coronavirus disease 2019 (COVID-19), a … The COVID-19 pandemic has led to …

… in English with a quantitative outcome related to mental health … COVID-19 patients discharged
from COVID-19 rehabilitation unit Cognitive dysfunction, psychotropic drug use, COVID-19 …

… We then identified the subgroup of COVID-19 positive patients for neuropsychiatric … chosen
any neuropsychiatric diagnosis on or within one month after diagnosis of COVID-19. These …

… This report of neurologic outcomes in a series of over 500 consecutive COVID-19 patients
in a Chicago-based hospital network found neurologic manifestations in approximately 80% of …

… The systemic manifestations of long‐COVID … neuropsychiatric outcomes. Thus, we aimed
to assess neurocognitive, psychiatric and QoL outcomes in a cohort of hospitalised COVID‐19 …

… neuropsychiatric outcomes measured were tabulated for each study. The number of patients
… experienced each outcome and number of patients in whom each particular outcome was …

… studies have examined the acute and post-illness psychiatric and neuropsychiatric outcomes
of these diseases. The COVID-19 pandemic has affected a large proportion of the world's …